Advertisement

Topics

This Biotech in London is Going After the Most Common Eye Disease

08:00 EST 24 Feb 2017 | Labiotech.eu

This week we strolled along the famous Hyde Park in London. Just a few meters from there, the biotech company TopiVert is developing a unique technology to treat inflammatory diseases.  Mission: TopiVert focuses on the development of Narrow Spectrum Kinase ...

This awesome article This Biotech in London is Going After the Most Common Eye Disease appeared first on Labiotech.eu. Be kind and don't copy it without asking ;)

Original Article: This Biotech in London is Going After the Most Common Eye Disease

NEXT ARTICLE

More From BioPortfolio on "This Biotech in London is Going After the Most Common Eye Disease"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...